Subcutaneous Immunoglobulins are a Valuable Treatment Option in Myasthenia Gravis

Detalles Bibliográficos
Autores principales: Garnero, Martina, Fabbri, Sabrina, Gemelli, Chiara, Benedetti, Luana, Mancardi, Giovanni Luigi, Schenone, Angelo, Grandis, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765263/
https://www.ncbi.nlm.nih.gov/pubmed/29141277
http://dx.doi.org/10.3988/jcn.2018.14.1.98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765263/
https://www.ncbi.nlm.nih.gov/pubmed/29141277
http://dx.doi.org/10.3988/jcn.2018.14.1.98

Ejemplares similares